Polo-like kinases (Plks) and cancer

Deregulated centrosome duplication or maturation often results in increased centrosome size and/or centrosome number, both of which show a positive and significant correlation with aneuploidy and chromosomal instability, thus contributing to cancer formation. Given the role of Polo-like kinases (Plks) in the centrosome cycle, it is not unexpected that deregulated expression of Plks is detected in many types of cancer and is associated with oncogenesis. Extensive studies have shown that Plk1 expression is elevated in non-small-cell lung cancer, head and neck cancer, esophageal cancer, gastric cancer, melanomas, breast cancer, ovarian cancer, endometrial cancer, colorectal cancer, gliomas, and thyroid cancer. Plk1 gene and protein expression has been proposed as a new prognostic marker for many types of malignancies, and Plk1 is a potential target for cancer therapy. In contrast to Plk1, several studies have observed that Plk3 expression is negatively correlated with the development of certain cancers.

[1]  D. Longo,et al.  Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. , 1997, Biochemical and biophysical research communications.

[2]  Y. Li,et al.  PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer , 2000, Genes, chromosomes & cancer.

[3]  Xiaoqi Liu,et al.  Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Hirabayashi,et al.  β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1) , 2003, Oncogene.

[5]  D. Glover,et al.  Polo kinase: the choreographer of the mitotic stage? , 1996, The Journal of cell biology.

[6]  A. Kumagai,et al.  Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg Extracts , 1996, Science.

[7]  N. Takai,et al.  Expression of polo-like kinase (PLK) in the mouse placenta and ovary. , 1999, Reproduction, fertility, and development.

[8]  N. Takai,et al.  Polo-like kinase (PLK) expression in endometrial carcinoma. , 2001, Cancer letters.

[9]  W. Weichert,et al.  Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma , 2004, British Journal of Cancer.

[10]  Ericka Stricklin-Parker,et al.  Ann , 2005 .

[11]  H. Ackermann,et al.  Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer , 1997, Oncogene.

[12]  Jürgen Bereiter-Hahn,et al.  Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. , 2002, Journal of the National Cancer Institute.

[13]  D. Slamon,et al.  prk, a Cytokine-inducible Human Protein Serine/Threonine Kinase Whose Expression Appears to be Down-regulated in Lung Carcinomas* , 1996, The Journal of Biological Chemistry.

[14]  J. Winkles,et al.  Identification by Targeted Differential Display of an Immediate Early Gene Encoding a Putative Serine/Threonine Kinase(*) , 1995, The Journal of Biological Chemistry.

[15]  B. Li,et al.  Human Prk Is a Conserved Protein Serine/Threonine Kinase Involved in Regulating M Phase Functions* , 1997, The Journal of Biological Chemistry.

[16]  J. Dennis,et al.  Comparative Expression of the Mitotic Regulators SAK and PLK in Colorectal Cancer , 2001, Annals of Surgical Oncology.

[17]  H. Lane,et al.  Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes , 1996, The Journal of cell biology.

[18]  A. Miyauchi,et al.  Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma , 2004, British Journal of Cancer.

[19]  D. Longo,et al.  Polo-like Kinase Is a Cell Cycle-regulated Kinase Activated during Mitosis (*) , 1995, The Journal of Biological Chemistry.

[20]  S. Zeuzem,et al.  Polo-like kinase1, a new target for antisense tumor therapy. , 2000, Biochemical and biophysical research communications.

[21]  Remo Guidieri Res , 1995, RES: Anthropology and Aesthetics.

[22]  Xiaoqi Liu,et al.  Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Venkitaraman,et al.  Phosphorylation of BRCA2 by the Polo-like kinase Plk1 is regulated by DNA damage and mitotic progression , 2004, Oncogene.

[24]  D. Glover,et al.  A conserved mitotic kinase active at late anaphase—telophase in syncytial Drosophila embryos , 1993, Nature.

[25]  N. Takai,et al.  Polo-like kinase expression in normal human endometrium during the menstrual cycle. , 2000, Reproduction, fertility, and development.

[26]  C. Mawrin,et al.  Increased Human Polo-Like Kinase-1 Expression in Gliomas , 2001, Journal of Neuro-Oncology.

[27]  R. Erikson,et al.  The polo-box-dependent induction of ectopic septal structures by a mammalian polo kinase, plk, in Saccharomyces cerevisiae. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Wiest,et al.  Intron/Exon organization and polymorphisms of the PLK3/PRK gene in human lung carcinoma cell lines , 2001, Genes, chromosomes & cancer.

[29]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[30]  H. Lane,et al.  On the regulation and function of human polo-like kinase 1 (PLK1): effects of overexpression on cell cycle progression. , 1997, Biochemical and biophysical research communications.

[31]  N. Takai,et al.  Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. , 2001, Cancer letters.